llab.bio

YANG LIU, PhD / BIOLOGICAL DISCOVERY

How life senses.
How life responds.

I explore the molecular signals that connect recognition to action—and the biology waiting to be discovered between them.

Explore the research
Microbial defense   /   RNA signaling   /   Molecular mechanismsResearch Fellow · Massachusetts General Hospital

01 / FUTURE RESEARCH VISION

Unexpected biology.
New possibilities.

Microbial evolution has produced an extraordinary range of ways to sense infection and respond. Many of the proteins and signals that make this possible remain unknown.

My future independent research will seek to discover unknown defense and signaling systems, define their mechanisms, and test how their molecular logic can inform human biology and programmable tools.

01

Discover the
unknown.

Which biological systems have we overlooked? I plan to explore public microbial genomes for unfamiliar defense proteins and pathways, using evolutionary context to identify candidates and experimental reconstruction to establish what they do.

MICROBIAL DIVERSITY · DEFENSE SYSTEMS

02

Decode the
signal.

How does recognition become a cellular response? I aim to uncover new roles for RNA fragments, small molecules, and protein modifications, and determine how these signals control the activity of their effectors.

RNA MESSENGERS · MOLECULAR REGULATION

03

Follow the
principle.

What can microbial mechanisms teach us across species? I will use conserved molecular features to test hypotheses about poorly understood proteins, then explore whether defined mechanisms can be adapted for programmable biological functions.

CONSERVED MECHANISMS · BIOENGINEERING

02 / SELECTED CONTRIBUTIONS

From a question
to a mechanism.

RNA SIGNALING

Small RNA fragments.
A different kind of signal.

I identified a tRNA-derived messenger that activates a protein kinase, connecting RNA cleavage to phosphorylation and transcriptional regulation.

Preprint · Nature (under revision)

View the work

MICROBIAL IMMUNITY

Revealing a new
immune effector.

As a co-first author, I contributed cryo-EM structures and RNA-seq analyses to work defining prokaryotic Schlafen proteins as signal-activated tRNA nucleases.

Nature Communications · 2026

View the work

HUMAN PROTEIN MECHANISMS

Understanding how
signaling proteins work.

My doctoral work combined biochemistry, functional assays, and structural analysis in collaborative studies of Wnt acylation, cholesterol uptake, and Hedgehog release.

Nature · Science Advances · Life Science Alliance

View the work

03 / PUBLICATIONS

Ideas, in print.

* Equal contribution where indicated.

Peer-reviewed publications

2026Nature
Communications

Prokaryotic Schlafen proteins cleave tRNAs during type III CRISPR immunity

Weickert P*, Liu Y*, Strecker J.

Nature Communications 17, 8219 (2026).

2022Nature

Mechanisms and inhibition of Porcupine-mediated Wnt acylation

Liu Y*, Qi X*, Donnelly L, Elghobashi-Meinhardt N, Long T, Zhou RW, Sun Y, Wang B, Li X.

Nature 607, 816–822 (2022).

2021Science Advances

Structures of dimeric human NPC1L1 provide insight into mechanisms for cholesterol absorption

Long T*, Liu Y*, Qin Y, DeBose-Boyd RA, Li X.

Science Advances 7, eabh3997 (2021).

2021Structure

Molecular structures of human ACAT2 disclose mechanism for selective inhibition

Long T, Liu Y, Li X.

Structure 29, 1410–1418.e4 (2021).

2021Talanta

Optimization of on-bead emulsion polymerase chain reaction based on single particle analysis

Siu RHP*, Liu Y*, Chan KHY, Ridzewski C, Slaughter LS, Wu AR.

Talanta 221, 121593 (2021).

2020Life Science Alliance

Structure of human Dispatched-1 provides insights into Hedgehog ligand biogenesis

Chen H*, Liu Y*, Li X.

Life Science Alliance 3, e202000776 (2020).

Preprint & manuscripts under revision

PREPRINTNature
(under revision)

A tRNA-derived second messenger mediates antiviral defense

Liu Y, Qin Y, Bouzit I, Yeung A, Chang H, Strecker J.

bioRxiv [Preprint]. Version 1, August 26, 2026. Manuscript under revision at Nature.

Read preprint
MANUSCRIPTNature
(under revision)

Diverse nucleases converge on tRNA-derived CCA signaling for antiviral defense

Qin Y*, Liu Y*, Weickert P, Strecker J.

Manuscript under revision at Nature.

04 / ABOUT

Yang LiuPhD

Research Fellow
Department of Molecular Biology
Massachusetts General Hospital

ORCID profile

I am interested in how cells detect infection and use molecular signals to mount a defense.

My research brings together the discovery of unknown microbial systems and the mechanistic study of human proteins. I use biochemical reconstitution, quantitative experiments, sequencing, and structural analysis to connect what a system does with how it works.

I am currently a Research Fellow in Jonathan Strecker’s laboratory at Massachusetts General Hospital. I previously trained in Feng Zhang’s laboratory at the Broad Institute and earned my PhD with Xiaochun Li at UT Southwestern Medical Center.

2024–present
Research FellowJonathan Strecker laboratory · Massachusetts General Hospital
2023–2024
Postdoctoral FellowFeng Zhang laboratory · Broad Institute of MIT and Harvard
2018–2023
PhD · Biomedical Sciences, Molecular BiophysicsUT Southwestern Medical Center · Advisor: Xiaochun Li
2014–2018
BS · Biochemistry and Cell BiologyHong Kong University of Science and Technology · Minor in Biophysics

05 / CONTACT

Good science starts
with a question.

For scientific conversations and research collaborations, get in touch.

yangliu@molbio.mgh.harvard.edu